Madrigal Pharmaceuticals Inc’s recent filing unveils that its Director CRAVES FRED B unloaded Company’s shares for reported $1.14 million on Dec 03 ’24. In the deal valued at $315.31 per share,3,600 shares were sold. As a result of this transaction, CRAVES FRED B now holds 11,000 shares worth roughly $3.02 million.
Then, CRAVES FRED B sold 3,400 shares, generating $1,191,028 in total proceeds. Upon selling the shares at $350.30, the Director now owns 14,600 shares.
Before that, CRAVES FRED B bought 10,000 shares. Madrigal Pharmaceuticals Inc shares valued at $3,227,300 were divested by the Director at a price of $322.73 per share.
Cantor Fitzgerald initiated its Madrigal Pharmaceuticals Inc [MDGL] rating to a Neutral in a research note published recently. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in mid June with a ‘”an Outperform”‘ rating. BofA Securities began covering MDGL with “an Underperform” recommendation on April 22, 2024. B. Riley Securities revised its rating on March 15, 2024. It rated MDGL as “a Neutral” which previously was an “a Sell”.
Price Performance Review of MDGL
On Tuesday, Madrigal Pharmaceuticals Inc [NASDAQ:MDGL] saw its stock fall -9.74% to $274.12. Over the last five days, the stock has lost -14.55%. Madrigal Pharmaceuticals Inc shares have fallen nearly -11.16% since the year began. Nevertheless, the stocks have risen 14.07% over the past one year. While a 52-week high of $368.29 was reached on 01/10/25, a 52-week low of $168.25 was recorded on 01/14/25. SMA at 50 days reached $317.53, while 200 days put it at $260.83.
Levels Of Support And Resistance For MDGL Stock
The 24-hour chart illustrates a support level at 263.65, which if violated will result in even more drops to 253.17. On the upside, there is a resistance level at 294.80. A further resistance level may holdings at 315.47. The Relative Strength Index (RSI) on the 14-day chart is 34.27, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -8.55, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 99.61%. Stochastics %K at 41.72% indicates the stock is a holding.
How much short interest is there in Madrigal Pharmaceuticals Inc?
A steep rise in short interest was recorded in Madrigal Pharmaceuticals Inc stocks on 2024-12-31, dropping by -0.17 million shares to a total of 4.11 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 4.28 million shares. There was a decline of -4.26%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on March 06, 2024 when Citigroup began covering the stock and recommended ‘”a Buy”‘ rating along with a $382 price target.
